Wind Relief chewable tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Aluminium hydroxide gel dried; Magnesium hydroxide; Simeticone

Available from:

The Boots Company Plc

ATC code:

n/a

INN (International Name):

Aluminium hydroxide gel dried; Magnesium hydroxide; Simeticone

Dosage:

351mg ; 164mg ; 25mg

Pharmaceutical form:

Chewable tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Never Valid To Prescribe As A VMP

Product summary:

BNF: 01010100; GTIN: 5045097628701

Patient Information leaflet

Bayer Ref No:
t Reference No:
Brand:
Range:
Product:
Pack Type:
Pack Size:
Action:
Date:
Country:
Finished Goods Code:
Synaps Request Code:
Component Code:
CAD Ref No:
Printer:
Packaging Site:
Substrate:
Barcode 1 Type:
Barcode 1 Mag:
Barcode 2 Type:
Barcode 2 Mag:
Pharmacode No/NE:
PIL 135 x 197
Rennie
Deflatine
Tablets
Leaflet
UK
Please note that any low resolution paper Canon colour
copies associated with this job should be referred to for
content, layout and colour separation only.
UNDER NO CIRCUMSTANCES SHOULD THIS
ARTWORK BE ALTERED WITHOUT PRIOR
PERMISSION FROM
STUDIO USE ONLY
v1.0
Sm•Art check results:
Cutter
Guides
Technical & Non Printing Items
BAYER ARTWORK PANEL
18/36 Pack
Packaging Site Approval:
ARTWORK
APPROVAL PANEL
Name:
Date:
Action:
Country Approval:
Name:
Date:
Action:
BAY371331
Main Text (body copy):
Height (based on lower case x):
10 pt
1.8 mm
FONT SIZE PANEL
1
LTH
Process Black
Colours
00000000
CALCIUM CARBONATE, MAGNESIUM CARBONATE, SIMETICONE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
ALWAYS TAKE THIS MEDICINE EXACTLY AS DESCRIBED IN
THIS LEAFLET OR AS YOUR DOCTOR OR PHARMACIST HAS
TOLD YOU.
-
KEEP THIS LEAFLET. YOU MAY NEED TO READ IT
AGAIN.
-
ASK YOUR PHARMACIST IF YOU NEED MORE
INFORMATION OR ADVICE.
-
IF YOU GET ANY SIDE EFFECTS, TALK TO YOUR DOCTOR
OR PHARMACIST. THIS INCLUDES ANY POSSIBLE SIDE
EFFECTS NOT LISTED IN THIS LEAFLET._ SEE SECTION 4._
-
YOU MUST CONTACT A DOCTOR IF YOU DO NOT FEEL
BETTER OR IF YOU FEEL WORSE AFTER 14 DAYS.
WHAT IS IN THIS LEAFLET
1.
WHAT RENNIE DEFLATINE IS AND WHAT IT IS
USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE
RENNIE DEFLATINE
3. HOW TO TAKE RENNIE DEFLATINE
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE RENNIE DEFLATINE
6. CONTENTS OF THE PACK AND OTHER INFORMATION
1. WHAT RENNIE® DEFLATINE IS AND WHAT IT
IS USED FOR
RENNIE DEFLATINE RELIEVES THE PAIN AND
DISCOMFORT OF BLOATING, BILIOUSNESS, FLATULENCE,
AND TRAPPED WIND. EACH TABLET IS FORMULATED
WITH SIMETICONE, A H

Summary of Product characteristics

OBJECT 1
BOOTS WIND RELIEF TABLETS
Summary of Product Characteristics Updated 14-Oct-2015 | THE BOOTS
COMPANY PLC
1. Name of the medicinal product
Indigestion Relief Tablets, Double Action Indigestion Tablets, Antacid
Plus Tablets, Gastricalm Tablets,
Boots Wind Relief Tablets
2. Qualitative and quantitative composition
Active ingredient
Quantity/Unit dose
Dried Aluminium Hydroxide Gel EP
(equivalent to 170mg aluminium oxide)
351 mg
Magnesium hydroxide EP
164 mg
Simethicone HSE or Silicone Antifoam M HSE
(activated methylpolysiloxane)
25 mg
3. Pharmaceutical form
Tablet.
4. Clinical particulars
4.1 Therapeutic indications
For relief from discomfort of painful wind, indigestion, heartburn and
excess acidity.
4.2 Posology and method of administration
For oral administration.
Adults and children over 12 years: One or two tablets to be sucked or
chewed after meals, at bedtime or
whenever discomfort is felt.
Children 5 to 12 years: One tablet to be sucked or chewed after meals,
at bedtime or whenever discomfort
is felt.
Children under 5 years: Not recommended.
Elderly: There is no need for dosage reduction in the elderly.
4.3 Contraindications
Hypersensitivity to any of the ingredients.
Hypophosphataemia.
4.4 Special warnings and precautions for use
This product should be used with caution in patients with impaired
renal function.
If symptoms persist for more than 5 days, consult your doctor.
Keep all medicines out of the reach of children.
4.5 Interaction with other medicinal products and other forms of
interaction
This product may interfere with the absorption of tetracyclines,
chloroquine, penicillamine,
phenothiazines and quinolone antibacterials, when these are given
concomitantly.
4.6 Pregnancy and lactation
There are no adequate human data from the use of aluminium hydroxide
and magnesium hydroxide in
pregnant women. Studies in animals have not been done. No data are
available to suggest any harmful
effects in pregnant women, associated with simethicone. Caution should
therefore be exercised when
taken by pregn